CRIBI Biotechnology Centre, University of Padua, Padua, Italy.
FEBS J. 2010 Jan;277(1):163-73. doi: 10.1111/j.1742-4658.2009.07466.x. Epub 2009 Nov 26.
The complexes formed by partially folded human and bovine alpha-lactalbumin with oleic acid (OA) have been reported to display selective apoptotic activity against tumor cells. These complexes were named human (HAMLET) or bovine (BAMLET) alpha-lactalbumin made lethal to tumor cells. Here, we analyzed the OA complexes formed by fragments of bovine alpha-lactalbumin obtained by limited proteolysis of the protein. Specifically, the fragments investigated were 53-103 and the two-chain fragment species 1-40/53-123 and 1-40/104-123, these last being the N-terminal fragment 1-40 covalently linked via disulfide bridges to the C-terminal fragment 53-123 or 104-123. The OA complexes were obtained by mixing the fatty acid and the fragments in solution (10-fold and 15-fold molar excess of OA over protein fragment) or by chromatography of the fragments loaded onto an OA-conditioned anion exchange column and salt-induced elution of the OA complexes. Upon binding to OA, all fragments acquire an enhanced content of alpha-helical secondary structure. All OA complexes of the fragment species showed apoptotic activity for Jurkat tumor cells comparable to that displayed by the OA complex of the intact protein. We conclude that the entire sequence of the protein is not required to form an apoptotic OA complex, and we suggest that the apoptotic activity of a protein-OA complex does not imply specific binding of the protein.
与油酸(OA)形成的部分折叠的人源和牛源α-乳白蛋白复合物已被报道具有针对肿瘤细胞的选择性细胞凋亡活性。这些复合物被命名为致瘤细胞杀伤的人源(HAMLET)或牛源(BAMLET)α-乳白蛋白。在此,我们分析了通过蛋白质有限水解获得的牛源α-乳白蛋白片段与 OA 形成的复合物。具体而言,研究的片段为 53-103 和双链片段物种 1-40/53-123 和 1-40/104-123,最后两个是通过二硫键共价连接的 N 端片段 1-40 与 C 端片段 53-123 或 104-123。OA 复合物通过在溶液中混合脂肪酸和片段(OA 对蛋白片段的摩尔比为 10 倍和 15 倍)获得,或者通过将片段加载到 OA 预处理的阴离子交换柱上,然后用盐诱导洗脱 OA 复合物获得。与 OA 结合后,所有片段均获得增强的α-螺旋二级结构含量。所有片段物种的 OA 复合物均显示出对 Jurkat 肿瘤细胞的凋亡活性,与完整蛋白的 OA 复合物相当。我们得出结论,形成凋亡性 OA 复合物不需要蛋白质的完整序列,并且我们建议蛋白质-OA 复合物的凋亡活性并不意味着蛋白质的特异性结合。